Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Label-free, arrayed sensing of immune response to influenza antigens.

Mace CR, Topham DJ, Mosmann TR, Quataert SA, Treanor JJ, Miller BL.

Talanta. 2011 Jan 15;83(3):1000-5. doi: 10.1016/j.talanta.2010.11.002. Epub 2010 Nov 10.

2.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
3.

Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.

Shoji Y, Chichester JA, Jones M, Manceva SD, Damon E, Mett V, Musiychuk K, Bi H, Farrance C, Shamloul M, Kushnir N, Sharma S, Yusibov V.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:41-50. Epub 2011 Jan 1.

PMID:
21266846
4.

Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.

Crevar CJ, Carter DM, Lee KY, Ross TM.

Hum Vaccin Immunother. 2015;11(3):572-83. doi: 10.1080/21645515.2015.1012013.

5.

Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.

Florek NW, Weinfurter JT, Jegaskanda S, Brewoo JN, Powell TD, Young GR, Das SC, Hatta M, Broman KW, Hungnes O, Dudman SG, Kawaoka Y, Kent SJ, Stinchcomb DT, Osorio JE, Friedrich TC.

J Virol. 2014 Nov;88(22):13418-28. doi: 10.1128/JVI.01219-14. Epub 2014 Sep 10.

6.

Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.

Guo CY, Tang YG, Qi ZL, Liu Y, Zhao XR, Huo XP, Li Y, Feng Q, Zhao PH, Wang X, Li Y, Wang HF, Hu J, Zhang XJ.

Immunobiology. 2015 Aug;220(8):941-6. doi: 10.1016/j.imbio.2015.02.002. Epub 2015 Feb 14.

PMID:
25708705
7.

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM.

PLoS One. 2008 Jan 30;3(1):e1501. doi: 10.1371/journal.pone.0001501.

8.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
9.

A biosensor based on electroactive dipyrromethene-Cu(II) layer deposited onto gold electrodes for the detection of antibodies against avian influenza virus type H5N1 in hen sera.

Jarocka U, Sawicka R, Stachyra A, Góra-Sochacka A, Sirko A, Zagórski-Ostoja W, Sączyńska V, Porębska A, Dehaen W, Radecki J, Radecka H.

Anal Bioanal Chem. 2015 Oct;407(25):7807-14. doi: 10.1007/s00216-015-8949-y. Epub 2015 Aug 22.

PMID:
26297459
10.

The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.

Lee JS, Chowdhury MY, Moon HJ, Choi YK, Talactac MR, Kim JH, Park ME, Son HY, Shin KS, Kim CJ.

J Virol Methods. 2013 Dec;194(1-2):280-8. doi: 10.1016/j.jviromet.2013.08.022. Epub 2013 Sep 1.

PMID:
24004822
11.

Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.

Zhu H, Ding X, Chen X, Yao P, Xu F, Xie R, Yang Z, Liang W, Zhang Y, Li Y, Shen J, He P, Guo Z, Su B, Sun S, Zhu Z.

Vaccine. 2011 Jul 26;29(33):5421-3. doi: 10.1016/j.vaccine.2011.05.067. Epub 2011 Jun 7.

PMID:
21645575
12.

Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.

Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.

J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.

13.

Immunology. Flu antibodies stir new hope for treatment, vaccine.

Leslie M.

Science. 2009 Feb 27;323(5918):1160. doi: 10.1126/science.323.5918.1160. No abstract available.

PMID:
19251602
14.

Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.

Patel A, Gray M, Li Y, Kobasa D, Yao X, Kobinger GP.

Vaccine. 2012 Jan 11;30(3):626-36. doi: 10.1016/j.vaccine.2011.11.017. Epub 2011 Nov 23.

PMID:
22119588
15.

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.

Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM, Gambotto A.

J Virol. 2006 Feb;80(4):1959-64.

17.

Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.

Prevato M, Ferlenghi I, Bonci A, Uematsu Y, Anselmi G, Giusti F, Bertholet S, Legay F, Telford JL, Settembre EC, Maione D, Cozzi R.

PLoS One. 2015 Aug 17;10(8):e0135474. doi: 10.1371/journal.pone.0135474. eCollection 2015.

18.

Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.

Holman DH, Wang D, Raja NU, Luo M, Moore KM, Woraratanadharm J, Mytle N, Dong JY.

Vaccine. 2008 May 19;26(21):2627-39. doi: 10.1016/j.vaccine.2008.02.053. Epub 2008 Mar 14.

PMID:
18395306
19.

Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt.

Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Daidoji T, Takagi T, Yasunaga T, Nakaya T, Ikuta K.

J Gen Virol. 2012 Oct;93(Pt 10):2215-26. doi: 10.1099/vir.0.044032-0. Epub 2012 Jul 12.

PMID:
22791605
20.

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.

Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L.

Vaccine. 2012 Nov 6;30(48):6833-8. doi: 10.1016/j.vaccine.2012.09.013. Epub 2012 Sep 18.

PMID:
23000130

Supplemental Content

Support Center